The Drug Enforcement Administration (DEA) has formally requested that federal health officials conduct a medical scientific review on psilocybin in response to a long-pending rescheduling petition. After initially denying advocates’ request to authorize a review into the psychedelic, last week DEA forwarded the request to move psilocybin from Schedule I to Schedule II of the […]
The Drug Enforcement Administration (DEA) has formally requested that federal health officials conduct a medical scientific review on psilocybin in response to a long-pending rescheduling petition. After initially denying advocates’ request to authorize a review into the psychedelic, last week DEA forwarded the request to move psilocybin from Schedule I to Schedule II of the Read More CANNABIS, MARIJUANA, SOCIAL MEDIA